Jump to content

Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network (Q45780030)

From Wikidata
scientific article published in March 1993
edit
Language Label Description Also known as
default for all languages
No label defined
    English
    Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network
    scientific article published in March 1993

      Statements

      Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network (English)

      Identifiers

       
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      edit